| Secondary |
| Nasopharyngitis |
19.2% |
| Drug Use For Unknown Indication |
17.3% |
| Asthma |
14.2% |
| Otitis Media Acute |
10.3% |
| Influenza |
5.8% |
| Bronchitis |
3.9% |
| Antitussive Therapy |
3.3% |
| Cough |
3.3% |
| Schizophrenia |
3.3% |
| Pneumonia |
3.1% |
| Product Used For Unknown Indication |
3.1% |
| Cardiac Failure |
2.8% |
| Upper Respiratory Tract Infection |
2.5% |
| Oropharyngeal Pain |
1.9% |
| Constipation |
1.7% |
| Upper Respiratory Tract Inflammation |
1.7% |
| Pyrexia |
0.8% |
| Bacterial Infection |
0.6% |
| Cardiac Failure Chronic |
0.6% |
| Convulsion |
0.6% |
|
| Hepatic Function Abnormal |
10.0% |
| Stevens-johnson Syndrome |
10.0% |
| Abnormal Behaviour |
8.0% |
| Erythema Multiforme |
8.0% |
| Pyrexia |
8.0% |
| Haematuria |
6.0% |
| Toxic Epidermal Necrolysis |
6.0% |
| Benign Prostatic Hyperplasia |
4.0% |
| Cardiac Failure Acute |
4.0% |
| Chromaturia |
4.0% |
| Hallucination, Visual |
4.0% |
| Jaundice |
4.0% |
| Mumps |
4.0% |
| Neutropenia |
4.0% |
| Ocular Hyperaemia |
4.0% |
| Thrombocytopenic Purpura |
4.0% |
| Agitation |
2.0% |
| Angina Pectoris |
2.0% |
| Brain Natriuretic Peptide Increased |
2.0% |
| Cardiac Failure |
2.0% |
|
| Concomitant |
| Influenza |
21.5% |
| Product Used For Unknown Indication |
12.8% |
| Drug Use For Unknown Indication |
12.3% |
| Bronchitis |
10.2% |
| Asthma |
8.4% |
| Cough |
7.1% |
| Nasopharyngitis |
4.7% |
| Pneumonia |
3.1% |
| Upper Respiratory Tract Inflammation |
2.9% |
| Ill-defined Disorder |
2.2% |
| Hypertension |
2.0% |
| Gastritis |
1.7% |
| Epilepsy |
1.6% |
| Pyrexia |
1.6% |
| Cancer Pain |
1.4% |
| Chronic Myeloid Leukaemia |
1.4% |
| Constipation |
1.4% |
| Insomnia |
1.3% |
| Otitis Media Acute |
1.2% |
| Productive Cough |
1.2% |
|
| Abnormal Behaviour |
21.1% |
| Delirium |
10.7% |
| Hallucination |
9.8% |
| Pneumonia |
7.1% |
| Pyrexia |
6.0% |
| Convulsion |
5.7% |
| Somnolence |
4.2% |
| Speech Disorder |
3.9% |
| Restlessness |
3.6% |
| Toxic Skin Eruption |
3.6% |
| Depressed Level Of Consciousness |
3.3% |
| Loss Of Consciousness |
3.3% |
| Tremor |
2.7% |
| Rash |
2.4% |
| Urinary Retention |
2.4% |
| Vision Blurred |
2.4% |
| Electrocardiogram Qt Prolonged |
2.1% |
| Hallucination, Visual |
2.1% |
| Weight Decreased |
2.1% |
| Enterocolitis Haemorrhagic |
1.8% |
|
